[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556543":3},{"organization":4,"armGroups":7,"interventions":26,"overallOfficials":32,"centralContacts":36,"locations":42,"responsibleParty":63,"collaborators":10,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":10,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":10,"enrollmentInfo":75,"targetDuration":10,"studyType":78,"phases":10,"briefSummary":79,"conditions":80,"keywords":84,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"China-Japan Friendship Hospital","OTHER",[8,14,18,22],{"label":9,"type":10,"description":11,"interventionNames":12},"Acute pulmonary embolism cohort",null,"1. Patients objectively confirmed acute symptomatic PE or PE with deep vein thrombosis (DVT)\n2. PE was confirmed by CTPA, lung V\u002FQ scan or pulmonary angiography.",[13],"Device: Artificial Intelligence",{"label":15,"type":10,"description":16,"interventionNames":17},"Chronic thromboembolic pulmonary disease without pulmonary hypertension cohort","1. Patients with functional impairment despite 3 months of adequate anticoagulation therapy after APE.\n2. CTPA\u002F pulmonary angiography or V\u002FQ scan showed unresolved thrombi in the pulmonary vessels.\n3. Without pulmonary hypertension at rest(mean pulmonary arterial pressure (mPAP) \\\u003C20 mmHg), as measured by right heart catheterization.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Chronic thromboembolic pulmonary hypertension cohort","1. Patients with functional impairment despite 3 months of adequate anticoagulation therapy\n2. CTPA\u002F pulmonary angiography or V\u002FQ scan showed unresolved thrombi in the pulmonary vessels.\n3. With pulmonary hypertension at rest (mean pulmonary arterial pressure (mPAP) \\>20 mmHg), as measured by right heart catheterization.",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Other pulmonary vascular disease cohort","Patients diagnosed with other pulmonary vascular disease including Takayasu arteritis, pulmonary artery sarcoma, and fibrosing mediastinitis.",[13],[27],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":10},"DEVICE","Artificial Intelligence","AI technology will provide novel imaging markers and generate a radiology report with relevant key slice imaging and evaluation results",[9,15,19,23],[33],{"name":34,"affiliation":5,"role":35},"Zhenguo Zhai, PhD","STUDY_DIRECTOR",[37],{"name":38,"role":39,"phone":40,"phoneExt":10,"email":41},"Min Liu, PhD","CONTACT","+86-10-84205056","mikie0763@126.com",[43],{"facility":44,"status":45,"city":46,"state":10,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"China-Japan Frendship hospital","RECRUITING","Beijing","100029","China","CN",{"type":51,"coordinates":52},"Point",[53,54],116.39723,39.9075,{"lat":54,"lon":53},[57,58,61],{"name":38,"role":39,"phone":40,"phoneExt":10,"email":41},{"name":34,"role":39,"phone":59,"phoneExt":10,"email":60},"+86-10-84206269","zhaizhenguo2011@126.com",{"name":38,"role":62,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":62,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Zhenguo Zhai,MD,PhD","Clinical Professor","100556543","chinese-pe-multimodality-imaging-artificial-intelligence-study-100556543",false,"NCT06526468","Chinese PE Multimodality Imaging Artificial Intelligence Study","CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study","Inclusion Criteria:\n\n* 14 Years and older\n* Patients suspected of PE\n\nExclusion Criteria:\n\n* Pregnant women\n* Refuse to follow up\n* Incomplete or discontinued imaging scans\n* Insufficient quality of image data to allow for analysis","ALL","14 Years",{"count":76,"type":77},1500,"ESTIMATED","OBSERVATIONAL","The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.",[81,82,83],"Pulmonary Embolism","Chronic Thromboembolic Pulmonary Hypertension","Chronic Thromboembolic Pulmonary Disease",[85,86,87,88,89],"imaging","early diagnosis","differential diagnosis","risk stratification","prognosis assessment","2024-08-27",{"date":92,"type":93},"2024-08-28","ACTUAL",{"date":95,"type":93},"2010-09-01",{"date":97,"type":77},"2028-09-01",{"name":5,"class":6},1]